Nephrotic syndrome in children: Prediction of histopathology from clinical and laboratory characteristics at time of diagnosis  by International Study of Kidney Disease in Children, 
Kidney International, Vol. 13 (1978), pp. 159 —165
Nephrotic syndrome in children: Prediction of histopathology
from clinical and laboratory characteristics at time of
diagnosis
A Repori of the International Study of Kidney Disease in Children
The nephrotic syndrome in children: Prediction of histopatholo-
gy from clinical and laboratory characteristics at time of diagnosis.
An international study of the primary nephrotic syndrome in
children was conducted between 1967 and 1974 in 24 clinics in
North America, Europe, and Asia. Systematic observations,
including renal biopsies, were made at the time of diagnosis,
before starting treatment, on 521 children between 12 weeks and
16 yr of age. The distribution of patients among histopathologic
categories revealed that 76.6% had minimal change nephrotic
syndrome (MCNS), 7.5% had membranoproliferative glomerulo-
nephritis (MPGN), and 6.9% had focal and segmental glomerulo-
sclerosis (FSGS). The most striking differences in clinical and
laboratory characteristics among patients with these three glomer-
ular diseases were between the MCNS and the MPGN groups.
Prediction of histopathology from univariate analyses of the data,
however, were far less accurate than generally believed. An equa-
tion obtained from multivariate analysis yielded very good dis-
crimination between patients with MPGN and those with other
forms of glomenilar disease. Limiting the performance of renal
biopsies before a trial of steroid therapy to patients predicted by
this equation to have MPGN would 1) avoid subjecting them to the
risk of steroid toxicity and 2) eliminate renal biopsies in those
patients with other forms of glomerular disease who respond to an
initial course of intensive steroid therapy.
Le syndrome nephrotique de l'enfant: Prevision de l'his-
topathologie a partir des caractéristiques ciniques et biolo-
giques au moment du diagnostic. Au cours dune étude interna-
tionale du syndrome nephrotique primaire de l'enfant qui a été
réalisée entre 1967 et 1974 dans 24 centres d'Amérique du Nord,
d'Europe et d'Asie, des observations systématiques, incluant les
biopsies rénales, out été recueillies avant l'institution du traite-
ment chez 521 enfants âgés de 12 semaines a 16 ans. La distribu-
tion des malades dans les categories histopathologiques montre
que 76,6% avaient des modifications minimes (MCNS), 7,5% des
glomérulonéphntes membrano-prolifératives (MPGN), et 6,9%
des glomérulonéphrites segmentaires et focales (FSGS). Les dif-
férences cliniques et biologiques les plus frappantes ont été obser-
vées entre MCNS et MPGN. Cependant la prevision de
l'histopathologie a partir d'analyses a une variable des observa-
tions s'est révélée beaucoup moms precise qu'on le croit generale-
ment. Une equation obtenue a partir d'une analyse a variables
multiples a donné une bonne discrimination entre les malades
atteints de MPGN et ceux ayant d'autres formes de maladies
glomerulaires. Si la réalisation de biopsies rénales avait été limitCe,
avant l'essai d'un traitement par les stéroides, aux malades classes
MPGN au moyen de cette equation 1) le risque de la toxicité des
stérdides aurait eté évité et 2) la biopsie n'aurait pas été faite aux
malades atteints d'autres lesions glomérulaires qui répondent a un
traitement intensif par les stéroIdes.
Since 1967, The International Study of Kidney
Disease in Children (ISKDC) has been conducting a
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multicenter, prospective study of children with the
nephrotic syndrome. Clinical and laboratory obser-
vations have been made on 521 patients, all of whom
had renal biopsies at the time of diagnosis, before
treatment was begun. This fourth in a series of
reports on these children [1-3] presents a) the distri-
bution of patients among the major histopathologic
categories associated with the primary nephrotic
syndrome in children and b) an analysis of the accu-
racy with which clinical and laboratory characteris-
tics observable at the time of diagnosis can be used
to predict histopathology and thus to substitute for
renal biopsy in directing therapy and predicting the
clinical course.
Subsequent reports on these patients will describe
their response to initial treatment with prednisone
and their long-term clinical course.
Methods
Patient selection. Between January 1967 and June
1974, 521 children with the nephrotic syndrome who
were older than 12 weeks and younger than 16 yr
were entered into the clinical survey from the 24
participating clinics (Table 1). The sample was not
entirely random, since it consisted of patients
referred to participating centers. However, patients
entered the study before biopsies had been done and
before treatment with prednisone had been started.
Since some clinical findings, such as hematuna and
hypertension, are generally believed to indicate seri-
ous disease, selective referral of such patients cannot
be excluded, and to the extent that it occurred, the
distribution of patients among histopathologic cate-
gories in the sample would not be representative of
the parent population of all children with the
nephrotic syndrome. It is believed that non-entry of
patients qualified for the survey did not introduce
appreciable bias. Of 373 patients seen in 13 of the
larger centers, only 14 (3.8%) were not entered, 10
because of lack of parental consent and 4 because of
0085—2538/78/0013—0160 $01.40
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Table 1. Distribution of patients among participating clinics
No. of
Clinics patients %
Table 2. Distribution of patients by histopathology
71 13.6
68 13.1
52 10.0
48 9.2
44 8.4
37 7.1
Categories
No. of
patients %
Minimal change nephrotic syndrome 398 76.4
Membranoproliferative glomerulonephritis 39 7.5
Focal & segmental glomerulosclerosis 36 6.9
Proliferative glomerulonephritis 12 2.3
Pure diffuse mesangial proliferation 12 2.3
Focal & global glomerulosclerosis 9 1.7
Membranous glomerulonephropathy 8 1.5
Chronic glomerulonephritis 3 0.6
Unclassified 4 0.8
Total 521 100
Total
31 6.0
25 4.8 sis, sex, geographic location, father's occupation; 2)
present history: age at time of apparent onset (recog-
23 4.4 nition of first symptom or finding), occurrence of
21 4.0 infections, immunizations, or allergic reactions dur-
17 3.3 ing the 8 weeks prior to diagnosis; 3) past history:
history of allergic reactions and renal disease; 4)
family history: family history of renal disease or high
12 2.3 blood pressure; 5) signs and symptoms: presence of
10 1.9 edema or signs of infection at time of diagnosis; 6)
9 1.7 physical examinations: height, weight, systolic and
6 1.2 diastolic blood pressure; 7) laboratory examinations:
6 12 as detailed below.
3 0.6 Collection of the data. Forms containing identify-
ing data and clinical and laboratory information for
3 0.6 each patient in each center were completed and for-
warded to the coordinating office. All forms were
2 0.4 checked manually for correctness and completeness,
1 0 2 and requests were made to retrieve missing informa-
tion. The initial data base, consisting of all informa-
1 0.2 tion gathered for each patient at the time of entry,
521 100 was coded for storage on magnetic tape and comput-
er-edited to check for inconsistencies in dates and
errors in values outside specified ranges.
Laboratory examinations. The following examina-
tions were done locally by methods used in the
individual participating laboratories: Blood: Urea
nitrogen, creatinine (Scr), cholesterol, total protein,
and albumin concentrations were measured. Urine:
(All evaluations were performed on the first morning
specimen of a timed overnight collection.) Tests
were performed to determine concentrations of red
blood cells, estimated by the counting chamber tech-
nique; concentrations of urinary protein, measured
densitometrically by using sulphosalicylic acid; rates
of excretion of red blood cells and protein, calculated
from concentrations and measured rates of urine
flow; and bacterial content, from cultures. Creati-
nine clearances: These were calculated from Scr and
rates of excretion of creatinine during a timed collec-
tion period.
The following examinations were done centrally:
a Clinics that admitted patients to the study for a period of less
than 3 yr.
inadequate cooperation. Patients with the following
clinical diagnoses were excluded from the study:
systemic lupus erythematosus, Schönlein-Henoch
purpura, amyloidosis, diabetes mellitus, syphilis,
drug nephropathy, metabolic errors such as cystinos-
is, malaria, sickle cell anemia, and congenital
cyanotic heart disease.
Definitions. Nephrotic syndrome was defined as
heavy proteinuria (> 40 mg/hr/rn2), determined quan-
titatively on an overnight collection of urine, accom-
panied by hypoalbuminemia (2.5 g/dl). The major
histopathologic categories are listed in Table 2 and
have been described elsewhere [2].
Survey procedures. The following items of infor-
mation were requested in the initial assessment: 1)
demographic characteristics: age at time of diagno-
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Serum C3 determinations were done in the labora-
tory of C. D. West, using an immunoelectrophoretic-
precipitin procedure [4]. IgGitransferrin clearance
ratios (protein selectivity) were measured in the lab-
oratory of J. S. Cameron, using the method of Cam-
eron and Blandford [5].
Standardization of variables. Because subjects
ranged in age from 12 weeks to 16 yr, many variables
had to be standardized for developmental changes
and for sex. Values for rates of urinary excretion of
red blood cells (RBC) and protein were corrected for
body surface area (BSA) and expressed as units/m2.
Ideal weight for height rather than actual weight was
used to calculate BSA to compensate for the varying
effects of edema.
Values for systolic and diastolic blood pressure [61
and for serum creatinine [7] were standardized for
age and sex using values for normal populations and
are expressed as percentiles. Actual values for the
percentiles for each age and sex are given in the
references cited. Values used to standardize for
height were those published by the National Center
for Health Statistics [8]. The use of these standards
for height of infants and children in the United States
fails to correct for international differences. Recent
studies, however, indicate that international differ-
ences in heights of children are diminishing. In addi-
tion, differences in body proportions, as described
by Greulich for Japanese children [91, impair at-
tempts to correct functional values for height or BSA.
Although values for serum cholesterol vary with
age [10], they were not standardized because the
degree of variation within the age range studied was
small.
Statistical analyses: 1) Univariate analyses. The
clinical and laboratory variables used were of several
kinds. Some were basically dichotomous; some had
few modalities and were dichotomized at some gen-
erally accepted cut-off point; some were quantitative
and continuous in nature but had to be adjusted for
developmental changes and sex so that percentiles
were used as critical values; some other quantitative
variables did not resemble normal curves in their
distribution, so that a comparison of means was not
appropriate. The comparisons of the three groups
were thus generally made in terms of proportions
falling above or below definite cut-off points. The
significance test used was primarily the x2 test with
one degree of freedom as applied to a 2 x 2 table.
Because 3 pair-wise comparisons were made
between the 3 groups, MCNS, FSGS, and MPGN,
2% was chosen as the critical level in order to main-
tain an overall significance level of approximately 5%
for the set of comparisons [11].
2) Multivariate analyses. Pair-wise comparisons
were made among the three groups in terms of a
battery of variables, taking account of their intercor-
relations. The analysis is an application of the linear
discriminant function [12], where many of the varia-
bles used are dichotomous. As such, it is also equiva-
lent to a multiple regression procedure and to Hotell-
ing's multivariate t test.
In addition, an equation was derived for discrimi-
nating one group of patients, the MPGN group, from
the mixture of all other patients by using the same
procedure, except that the step-up multiple linear
regression computer program [13] permitted a reduc-
tion in the number of variables.
Results
A) Distribution of patients among histopathologic
categories (Table 2). Of 521 patients with the prima-
ry nephrotic syndrome, about 90% had either MCNS
(76.4%), MPGN (7.5%), or FSGS (6.9%). Among the
39 patients with MPGN, 30 had type 1 with suben-
dothelial deposits, and 9 had type 2 disease with
intramembranous dense deposits. The clinical and
laboratory characteristics of these two groups did
not differ at the time of diagnosis, and therefore, they
are analyzed as a single group in this report.
B) Associations between glomerular histopatholo-
gy in patients with MCNS, FSGS, and MPGN and
clinical and laboratory characteristics at time of
diagnosis. Data presented and analyzed in this paper
are limited to those obtained from patients with
MCNS, FSGS, and MPGN, since the number of
patients in the other histopathologic categories was
too small to permit statistical analysis.
1) Univariate analyses. The proportion of patients
with clinical and laboratory characteristics common-
ly used to differentiate among the major forms of
primary glomerular diseases associated with the
nephrotic syndrome are shown in Table 3. For each
characteristic listed, with the exception of serum
creatinine, there was a statistically significant differ-
ence (P < 0.01) between at least two of the three
groups of patients compared. The cut-off point for
age at 6 yr was chosen visually from the cumula-
tive frequencies of age at time of diagnosis shown in
Figure 1. The cut-off points for blood pressure and
serum creatinine are at the 98th percentile, repre-
senting two standard deviations above the mean for
the normal population corrected for age and sex. The
value taken to indicate the presence of hematuria (>
100,000 RBC/m2!hr) is equivalent to 1,200,000 RBC
per 12-hr overnight specimen. This value is well
above the range of normal values reported for chil-
dren [14]. The cut-off point for serum C3 [15] and the
values for highly and poorly selective proteinuria
[16] are those generally described in the literature.
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Table 3. Proportion of patients in the ISKDC with clinical and
laboratory characteristics used commonly at time of diagnosis to
differentiate among the major forms of primary glomerular disease
associated with the nephrotic syndrome in childrena
MCN
Characteristics n/Nt'
S
%
FSG
n/Na
S
%
MPG
n/Na
N
%
Age,n 6b.c.d 3 17/398 79.6 18/36 50.0 1/39 2.6
Sex: female' 135/398 39.9 11/36 30.6 25/39 64.1
BP
> 98th percentile;
Systolic 72/347
Diastolice 47/347
20.7
13.5
16/33
11/33
48.5
33.3
19/37
10/37
51.4
27.0
Hematunab,c
RBC
> 100,000 m2/hr 80/352 22.7 15/31 48.4 20/34 58.8
Serum C3d
< 90 mg/dl 4/275 1.5 1/27 3.7 26/35 74.3
Serum
cholesterolb
< 250 mg/dl 21/387 5.4 3/35 8.6 7/36 19.4
Selectivity index:
Highly selective
< •0lb 110/208
Non-selective
.02 32/208
52.9
15.4
3/23
13/23
13.0
56.5
1/10
6/10
10.0
60.0
Serum creatinine,
> 98thpercentile 1121345 32.5 13/32 40.6 19/38 50.0
a Abbreviations used are MCNS, minimal change nephrotic
syndrome; FSGS, focal and segmental glomerulosclerosis;
MPGN, membranoproliferative glomerulonephritis; n, number
with characteristics; N, total number.
b MCNS vs. MPGN, P <0.01.
MCNS vs. FSGS, P <0.01.
d FSGS vs. MPGN, P <0.01.
Fig. 1. Age at time of diagnosis of patients with minimal change
nephrotic syndrome (MCNS), focal and segmental glomeruloscle-
rosis (FSGS), and membranoprol(ferative glomerulonephritis
(MPGN). Cumulative percentages are shown. Median values are
MCNS, 3 yr; FSGS, 6 yr; MPGN, 10 yr.
Table 4. Relative contributions of selected variables in differentiat-
ing between histopathologic categories (expressed as standardized
regression coefficient without regard to sign)a
Characteristic
MCNS vs.
MPGN
MCNS vs.
FSGS
FSGS vs.
MPGN
Age at diagnosis 0.0681 0.0002 0.2375
Sex 0.0255 0.0403 0. 1015
Edema 0.1566 0.0709 0.0877
Systolic BP 0.0536 0.0758 0.3 140
Diastolic BP 0.0307 0.2240 0.3895
Hematuria 0.1258 0.1766 0.1888
Urinary protein 0.0098 0. 1299 0.1044
Serum albumin 0.1031 0.0221 0.1685
Serum creatinine 0.1985 0.0408 0. 1030
Serum C 0.6037 0.0477 0.5802
Serum cholesterol 0.0450 0.03 16 0. 1003
% of variability of Y
(r2) accounted for 72.3 16.4 86.6
a Abbreviations used are MCNS, minimal change nephrotic
syndrome; MPGN, membranoproliferative glomerulonephritis;
FSGS, focal and segmental glomerulosclerosis.
a,
Co
Co
0
00
C
0
0
cCC
ci)
g
Age, yr
include 8 of the 9 listed in Table 3 plus urinary
protein, serum albumin, and edema. Selectivity
index was excluded because it was measured in so
few patients with MPGN.
For each comparison, the regression coefficients
(linear combining coefficients of the discriminant
function) are given in standardized form (beta
weights) without regard to sign (Table 4). The magni-
tude of these coefficients corresponds to the order of
importance the variable has in distinguishing one
histopathological group from another. It must be
emphasized, however, that the relative magnitudes
of these coefficients depend on the set of variables
being used; they are also sensitive to sampling
variation.
Univariate analyses of data on other clinical and
laboratory characteristics of these patients (see Sur-
vey Procedures and Methods) are not presented at
this time since their relevance to the prediction of
histopathology at time of diagnosis is not apparent.
Their significance may become more clear when they
are analyzed together with data on response to initial
treatment with prednisone and the subsequent
course. Some of these variables, however, were used
in the multivariate analyses.
2) Multivariate analyses: a) Pair-wise compari-
sons between MCNS and MPGN, MCNS and
FSGS, and MPGN and FSGS. A standard multiple
linear regression analysis was performed for each
comparison, using group membership (MCNS,
MPGN, or FSGS) as the dependent variable (Y = 0
or 1). For the independent X variables, 11 were
selected on the basis of their being generally consid-
ered to have clinical relevance. The 11 variables used
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From the proportion of the variability of Y
accounted for by the multiple regression (r2 in Table
4), it is apparent that MPGN is sharply separated
from MCNS and FSGS, but that the latter two are
not sharply separated. Conventional significance
tests based on r2 are not entirely appropriate here
because of the nature of the X variables, although, if
done, they would show high significance for all the
pair-wise comparisons [10].
b) Discrimination of one histopathological group
from the mixture of all other patients. As discussed
subsequently, it would be most useful to be able to
distinguish the group of patients with MCNS from all
other patients on the basis of their clinical and labo-
ratory characteristics; however, it was found impos-
sible to do this with either univariate or multivariate
analyses. The characteristics of the group of patients
with MCNS differ greatly from those of the MPGN
group, but they are rather similar to those of patients
in the other histopathological categories. Conse-
quently, the compromise was arrived at of trying to
differentiate the MPGN group from all others. The
discriminant function or multiple regression
approach was again used in which group member-
ship (Y = 0 or 1) was the dependent variable. In
addition to the 11 variables listed in Table 4 for the
pair-wise comparisons, 6 other variables of less cer-
tain clinical relevance, but for which complete data
were available for many patients, were used in the
analysis; these were height, weight, signs of infec-
tion, serum total protein, creatinine clearance, and
RBC <30,000/m2/hr.
Among the 521 children with the primary nephrot-
ic syndrome, there were 25 patients with MPGN and
224 with other forms of histopathology in whom
these 17 variables had been measured. After the
step-up programa 5 variables remained in the equa-
tion. There were an additional 3 patients with MPGN
and 24 with other forms of histopathology who had
measurements of these 5 variables and on whom the
equation performed satisfactorily. The final equation
was derived using these 27 additional patients. This
equation expressing the estimated relationship
between 5 clinical and laboratory characteristics
selected by computer program on the basis of their
discriminatory power and the Y value (Y = 0 for
patients with MPGN, Y = I for all others) is:
Y= —0.6511X3 + 0.2239X — 0.0990X8
— 0.0580X11 — 0.0721X14 + 0.9295
a An F value (ratio of variance estimates) of 4.0 was used to enter
or remove variables from the equation [13].
where X3 = serum C3 (0 = 90 mg/dl, 1 = <90 mg/
dl); X6 = edema (0 = absent, 1 = present); X8 =
serum creatinine (mg/dl); X11 = serum albumin (gI
d!); X14 = hematuria (0 = 100,000 RBC/m2/hr, 1 =
> 100,000 RBC/m2lhr.
The estimated Y represented by 'was computed
for each of the 276 patients. The distribution of Y is
shown in Figure 2. It can be seen that there is
relatively little overlap of the distributions of Y for
MPGN and for others. This is due to the fact that the
multiple regression equation accounts for a high pro-
portion (67.5%) of the variability in Y. Errors of
classification can be calculated for the available
patients from these distributions by using different
cut-off points, . For example, if is chosen as
0.85, the decision that every patient below this value
would have MPGN and that every patient above this
value would belong to some other histopathological
group would result in no misclassification for
MPGN, and only 22/248 or 8.9% of the other patients
would be erroneously classified as MPGN. Since this
assessment is based on the same data from which the
equation is calculated, it must be regarded as opti-
mistic for purposes of classifying future patients.
Discussion
Optimal treatment of a child presenting with the
nephrotic syndrome requires knowledge of the
underlying glomerular disease with which it is associ-
ated. For many years, the absence of hematuria,
hypertension, and reduced GFR in patients with the
primary nephrotic syndrome has been interpreted as
indicating a good prognosis. More recently, the
absence of these signs of nephritis together with
other findings, such as highly selective proteinuria
and normal levels of serum C3, have been considered
to be characteristic of patients with MCNS and to
provide good discrimination between these patients
and those with recognized forms of glomerular
histopathology.
Despite wide acceptance of these clinical impres-
sions, their validity has not been critically assessed.
Data presented in the two reports [17, 18] of clinico-
pathologic correlations in relatively large samples of
children suggest that predictions of glomerular histo-
pathology from clinical and laboratory characteris-
tics at time of onset may be less accurate than gener-
ally held. Thus, among the 291 patients with MCNS
reported by Habib and Kleinknecht [17], 36% had
hematuria, 10% had blood urea levels over 60 mg/dl,
6% had hypertension, and 25% had only moderately
selective or nonselective proteinuria. Among the ill
patients with MCNS reported by White, Glasgow,
and Mills [18], 13% had hematuria, 9% had hyper-
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Fig. 2. Distribution of values for patients with membranoproli-
ferative glomerulonephritis (MPGN) and for those with other
glomerular diseases.
tension, and 19% had blood urea values above 40 mgI
dl.
The data presented here on a large number of
children with the primary nephrotic syndrome, who
had renal biopsies at the time of diagnosis before
starting treatment, permit detailed analysis of the
accuracy of predicting histopathology from clinical
and laboratory characteristics at the time of
diagnosis.
Examination of Table 3 reveals that children with
MCNS differ from those with MPGN in almost every
variable listed, whereas some characteristics of
patients with FSGS are similar to those of MCNS
(sex and serum C3), while others are similar to those
of patients with MPGN (hypertension and hematu-
na), and still others are intermediate (serum creati-
nine, protein selectivity).
Knowledge of these various relationships has giv-
en many clinicians confidence that they can differen-
tiate fairly well between patients with these three
glomerular diseases associated with the nephrotic
syndrome, especially between those with MCNS and
MPGN. Further analyses of data in Table 3, how-
ever, reveal how inaccurate such predictions would
have been. For example, in this series, predicting
that a child did not have MCNS because he had a low
C3 would almost always have been correct since only
1.5% of patients with MC had low values. However,
predicting that he did not have MPGN because he
had a normal C3 would have been incorrect in about
one-fourth of the cases with MPGN. Similarly, pre-
dicting that a patient did not have MCNS because he
had hematuria would have been incorrect in more
than one-fifth of the cases with MCNS, whereas
predicting that a patient did not have MPGN because
there was no hematuria would have been incorrect in
more than two-fifths of patients with MPGN.
The equation obtained from multivariate analyses
of more extensive data permits more accurate pre-
dictions of the underlying glomerular disease. As
stated earlier, a good discrimination between MCNS
and others would be most desirable since an impor-
tant clinical goal is to avoid biopsies at the time of
diagnosis in patients with MCNS and to biopsy all
others before starting prednisone therapy. Since this
discrimination is poor, the next most desirable dis-
crimination would be between MPGN and all others,
since patients with MPGN should not be given large
dosages of steriods, whereas in the absence of persis-
tent hypertension, other patients could be treated
with steroids and have biopsies only if they continue
to have proteinuria.
Fortunately, the discrimination between MPGN
and other glomerular diseases is very sharp. Conse-
quently, in this series, if a biopsy had been recom-
mended before giving intensive steroid treatment in
patients with values less than 0.85, no cases of
MPGN would have been missed, and a biopsy would
have been done in less than 8% of patients with MC.
Conversely, if patients with Y values greater than
0.85 had been treated without doing a biopsy, no
patients with MPGN would have been included'.
Thus, with the assistance of such an equation, and
using the same characteristics upon which the clini-
cian usually bases his clinical judgment, his decision
concerning whether or not to do a biopsy before
starting treatment could be made with a quantitative
estimate of the accuracy of his prediction.
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Children, 1300 Morris Park Avenue, Bronx, New York 10461,
U.S.A.
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